George Kamajian, DO
General Practice · Goleta, CANPI 1013963974
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.1% of the total across 149 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $867 and has fallen 87.7% since, to $106 in 2025. Among general practice clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 149 payments — averaging $19.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Orexo US, Inc.$553
- AbbVie$371
- Merz North America, Inc.$321
- Smith+Nephew$260
- Organogenesis Inc.$241
- Biodelivery Sciences International, Inc.$228
- plus $940 from 20 others
What the payments were for
- Speaking & faculty fees$1234%
- Food & beverage$2,77395%
- Education$191%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Orexo US, Inc. | 41 | $553 |
| AbbVie(2 entities) | 16 | $371 |
| Merz North America, Inc. | 3 | $321 |
| Smith+Nephew | 12 | $260 |
| Organogenesis Inc. | 2 | $241 |
| Biodelivery Sciences International, Inc. | 21 | $228 |
| Indivior Inc. | 13 | $199 |
| Misonix Inc | 1 | $143 |
| Galderma Laboratories, L.p. | 8 | $104 |
| Eisai Inc. | 3 | $58 |
| GSK | 3 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $51 |
| Pfizer | 3 | $43 |
| Aroa Biosurgery Incorporated | 2 | $42 |
| Alkermes, Inc. | 2 | $37 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $36 |
| Braeburn Inc. | 2 | $30 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Integra Lifesciences Corporation | 1 | $16 |
| Novo Nordisk | 1 | $16 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Almatica Pharma LLC | 1 | $14 |
| Gilead | 1 | $13 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XEOMIN$300
- ASCLERA$300
- Apligraf$123
- Dermagraft$123
- Puraply/Affinity/NuTech$123
- PuraPly$118
How this compares
$2,915 in reported general payments places this provider in the 90th percentile of 12,963 general practice providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 163 | $5,074 |
| Morphine Sulfate ErMorphine Sulfate | 55 | $1,682 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 29 | $966 |
| Gabapentin | 41 | $403 |
| Hydromorphone Hcl | 13 | $230 |
| Tizanidine Hcl | 25 | $176 |
| Methadone Hcl | 16 | $160 |
| Cyclobenzaprine Hcl | 12 | $112 |
| Baclofen | 12 | $84 |
| Meloxicam | 19 | $77 |
| Metoprolol Tartrate | 11 | $58 |
| Atorvastatin Calcium | 12 | $34 |
Paid to pharmacies, not to this prescriber.
Other general practice in Goleta
- Nathan LiLancaster$5.2M
- Milton McCollSan Jose$4.9M
- Frederic MollRedwood City$2.5M
- Bradley ChingUpland$1.4M
- Eric BrassTorrance$755K
- Marc GeissbergerGreenbrae$583K
- Robert CampbellLong Beach$501K
- Varo BoyerNorth Hills$482K
- Michael MiyasakiSacramento$464K
- Apolinar MadrigalCeres$419K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.